未登录
分享
收藏
分享
收藏
分享
收藏
分享
收藏Dupilumab Provides Acceptable Safety and Sustained Efficacy for up to 4 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic Dermatitis
Beck, Lisa A.; Deleuran, Mette; Bissonnette, Robert; de Bruin-Weller, Marjolein; Galus, Ryszard; Nakahara, Takeshi; Seo, Seong Jun; Khokhar, Faisal A.; Vakil, Jignesh; Xiao, Jing; Marco, Ainara Rodriguez; Levit, Noah A.; O'Malley, John T.; Shabbir, Arsalan
分享
收藏
分享
收藏
分享
收藏
分享
收藏Continued Treatment with Dupilumab is Associated with Improved Efficacy in Adults with Moderate-to-Severe Atopic Dermatitis Not Achieving Optimal Responses with Short-Term Treatment
Armstrong, April; Blauvelt, Andrew; Simpson, Eric L.; Smith, Catherine H.; Herranz, Pedro; Kataoka, Yoko; Seo, Seong Jun; Ferrucci, Silvia M.; Chao, Jingdong; Chen, Zhen; Rossi, Ana B.; Shumel, Brad; Tomondy, Paul
分享
收藏
分享
收藏
分享
收藏Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis and Prior Use of Systemic Non-Steroidal Immunosuppressants: Analysis of Four Phase 3 Trials
Griffiths, Christopher; de Bruin-Weller, Marjolein; Deleuran, Mette; Fargnoli, Maria Concetta; Staumont-Salle, Delphine; Hong, Chih-Ho; Sanchez-Carazo, Jose; Foley, Peter; Seo, Seong Jun; Msihid, Jerome; Chen, Zhen; Cyr, Sonya L.; Rossi, Ana B.
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏